metformin has been researched along with thiazolidines in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Woo, V | 1 |
| Beck-Nielsen, H; Home, PD; Jones, NP; Kahn, SE; Noronha, D; Viberti, G | 1 |
| Schwanstecher, C; Schwanstecher, M | 1 |
| Cha, BY; Chul Jang, HC; Chung, CH; Han, KA; Jang, WI; Kim, KA; Kim, MK; Ku, BJ; Lee, HW; Lee, MK; Park, IB; Park, JY; Park, KS; Rhee, EJ; Woo, AC | 1 |
| Akimoto, K; Davies, M; Hayashi, Y; Hisanaga, N; Jürgen Heuer, H; Nakamaru, Y | 1 |
| Gu, W; Guo, X; Ji, L; Lu, J | 1 |
| Bryson, A; Deak, L; Jennings, PE; Lawson, M; Paveliu, FS | 1 |
| Allakonda, L; Paul, D; Satheeshkumar, N | 1 |
| Sanyal, M; Shah, PA; Shrivastav, PS; Vanol, PG | 1 |
| Aggarwal, D; Bishnoi, A; Guliani, A; Parsad, D | 1 |
| Choi, KM; Jang, HC; Kang, ES; Kim, DJ; Kim, ES; Kim, NH; Kim, SJ; Kim, SR; Kim, Y; Lee, MK; Oh, T; You, J | 1 |
| Bhutani, R; Bodla, RB; Kant, R; Kapoor, G | 1 |
| Kashiv, P; Kumar, J | 1 |
| Kim, JH; Lee, BW; Lee, M; Lee, WJ | 1 |
1 review(s) available for metformin and thiazolidines
| Article | Year |
|---|---|
Targeting type 2 diabetes.
Topics: Adipose Tissue; Caloric Restriction; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Metformin; Signal Transduction; Thiazolidines | 2011 |
6 trial(s) available for metformin and thiazolidines
| Article | Year |
|---|---|
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Thiazolidines; Treatment Outcome | 2010 |
Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pyrazoles; Republic of Korea; Thiazolidines | 2015 |
Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults.
Topics: Adult; Area Under Curve; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Metformin; Middle Aged; Pyrazoles; Thiazolidines; Young Adult | 2015 |
The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pyrazoles; Thiazolidines; Treatment Outcome | 2016 |
Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazoles; Republic of Korea; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidines; Treatment Failure | 2019 |
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled study.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Prospective Studies; Pyrazoles; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines; Treatment Outcome | 2022 |
7 other study(ies) available for metformin and thiazolidines
| Article | Year |
|---|---|
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nath
Topics: Algorithms; Diabetes Mellitus, Type 2; Europe; Evidence-Based Medicine; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Societies, Medical; Thiazolidines; United States | 2009 |
[The impact of glycosylated hemoglobin target value in treatment guidelines on glycemic control of type 2 diabetic in Chinese cities].
Topics: Adult; Aged; Asian People; Blood Glucose; China; Cities; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Outpatients; Sulfonylurea Compounds; Thiazolidines; Treatment Outcome | 2015 |
A validated UHPLC-QTOF-MS method for quantification of metformin and teneligliptin in rat plasma: Application to pharmacokinetic interaction study.
Topics: Animals; Chromatography, High Pressure Liquid; Mass Spectrometry; Metformin; Pyrazoles; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Thiazolidines | 2017 |
Mechanistic study for the simultaneous determination of metformin and teneligliptin in human plasma using hydrophilic interaction liquid chromatography-MS/MS.
Topics: Chromatography, Liquid; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Metformin; Plasma; Pyrazoles; Tandem Mass Spectrometry; Thiazolidines | 2018 |
Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Male; Metformin; Pemphigoid, Bullous; Pyrazoles; Thiazolidines; Treatment Outcome | 2018 |
Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.
Topics: Adamantane; Benzhydryl Compounds; Chromatography, High Pressure Liquid; Dipeptides; Dose-Response Relationship, Drug; Gliclazide; Glucosides; Linagliptin; Metformin; Molecular Structure; Pioglitazone; Pyrazoles; Software; Structure-Activity Relationship; Thiazolidines | 2019 |
Eff ectiveness of Teneligliptin as an Add-on in T2DM Patients not Controlled on Metformin and Glimepiride.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pyrazoles; Sulfonylurea Compounds; Thiazolidines | 2020 |